IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Corvus Pharmaceuticals Inc

Q4 2024 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
DCF Advisers, LLC
INCREASED
Shares768,500 from 28,681
Change+739,819 (+2579%)
Value$5.7M (+$5.5M)
Filed 2025-11-12
Status
DCF Advisers, LLC
INCREASED768,50028,681+739,819+2579%$153.4K$5.7M+$5.5M2025-11-12
Showing 1 of 1 institutions